nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Methoxsalen—hematologic cancer	0.0366	0.0523	CbGbCtD
Tranylcypromine—CYP1A2—Anagrelide—hematologic cancer	0.0313	0.0447	CbGbCtD
Tranylcypromine—CYP2A6—Ifosfamide—hematologic cancer	0.0267	0.0381	CbGbCtD
Tranylcypromine—CYP2E1—Thalidomide—hematologic cancer	0.02	0.0286	CbGbCtD
Tranylcypromine—CYP2C9—Bexarotene—hematologic cancer	0.0195	0.0279	CbGbCtD
Tranylcypromine—CYP2A6—Prednisolone—hematologic cancer	0.0178	0.0254	CbGbCtD
Tranylcypromine—CYP2E1—Dacarbazine—hematologic cancer	0.0172	0.0246	CbGbCtD
Tranylcypromine—CYP2D6—Lomustine—hematologic cancer	0.0166	0.0237	CbGbCtD
Tranylcypromine—CYP1A2—Carmustine—hematologic cancer	0.0164	0.0235	CbGbCtD
Tranylcypromine—CYP2C9—Idarubicin—hematologic cancer	0.0162	0.0231	CbGbCtD
Tranylcypromine—CYP2D6—Idarubicin—hematologic cancer	0.0148	0.0211	CbGbCtD
Tranylcypromine—CYP2C19—Bortezomib—hematologic cancer	0.0144	0.0206	CbGbCtD
Tranylcypromine—CYP1A2—Methoxsalen—hematologic cancer	0.014	0.0199	CbGbCtD
Tranylcypromine—CYP2E1—Mitoxantrone—hematologic cancer	0.0134	0.0191	CbGbCtD
Tranylcypromine—CYP1A2—Bortezomib—hematologic cancer	0.0133	0.019	CbGbCtD
Tranylcypromine—CYP1A2—Daunorubicin—hematologic cancer	0.0127	0.0181	CbGbCtD
Tranylcypromine—CYP2D6—Hydroxyurea—hematologic cancer	0.0126	0.018	CbGbCtD
Tranylcypromine—CYP2C19—Thalidomide—hematologic cancer	0.0125	0.0179	CbGbCtD
Tranylcypromine—CYP1A2—Alitretinoin—hematologic cancer	0.0124	0.0178	CbGbCtD
Tranylcypromine—CYP2C9—Bortezomib—hematologic cancer	0.012	0.0171	CbGbCtD
Tranylcypromine—CYP2C19—Teniposide—hematologic cancer	0.012	0.0171	CbGbCtD
Tranylcypromine—CYP1A2—Thalidomide—hematologic cancer	0.0116	0.0165	CbGbCtD
Tranylcypromine—CYP3A4—Bexarotene—hematologic cancer	0.0114	0.0162	CbGbCtD
Tranylcypromine—CYP2C19—Ifosfamide—hematologic cancer	0.011	0.0158	CbGbCtD
Tranylcypromine—CYP2D6—Bortezomib—hematologic cancer	0.0109	0.0156	CbGbCtD
Tranylcypromine—CYP3A4—Lomustine—hematologic cancer	0.0106	0.0151	CbGbCtD
Tranylcypromine—CYP3A4—Busulfan—hematologic cancer	0.0106	0.0151	CbGbCtD
Tranylcypromine—CYP2C19—Imatinib—hematologic cancer	0.0105	0.0151	CbGbCtD
Tranylcypromine—CYP2A6—Dexamethasone—hematologic cancer	0.0105	0.015	CbGbCtD
Tranylcypromine—CYP2C9—Thalidomide—hematologic cancer	0.0104	0.0149	CbGbCtD
Tranylcypromine—CYP1A2—Dacarbazine—hematologic cancer	0.00995	0.0142	CbGbCtD
Tranylcypromine—CYP2C9—Teniposide—hematologic cancer	0.00995	0.0142	CbGbCtD
Tranylcypromine—CYP1A2—Imatinib—hematologic cancer	0.00973	0.0139	CbGbCtD
Tranylcypromine—CYP3A4—Thiotepa—hematologic cancer	0.00941	0.0134	CbGbCtD
Tranylcypromine—CYP2C9—Ifosfamide—hematologic cancer	0.00918	0.0131	CbGbCtD
Tranylcypromine—CYP2C9—Imatinib—hematologic cancer	0.00877	0.0125	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—hematologic cancer	0.00842	0.012	CbGbCtD
Tranylcypromine—CYP2D6—Imatinib—hematologic cancer	0.00802	0.0115	CbGbCtD
Tranylcypromine—CYP2C9—Nilotinib—hematologic cancer	0.00797	0.0114	CbGbCtD
Tranylcypromine—CYP1A2—Dasatinib—hematologic cancer	0.00782	0.0112	CbGbCtD
Tranylcypromine—CYP3A4—Methoxsalen—hematologic cancer	0.00732	0.0105	CbGbCtD
Tranylcypromine—CYP2D6—Nilotinib—hematologic cancer	0.00729	0.0104	CbGbCtD
Tranylcypromine—CYP2D6—Vinorelbine—hematologic cancer	0.00723	0.0103	CbGbCtD
Tranylcypromine—CYP3A4—Bortezomib—hematologic cancer	0.00696	0.00994	CbGbCtD
Tranylcypromine—CYP2C19—Prednisone—hematologic cancer	0.00695	0.00993	CbGbCtD
Tranylcypromine—CYP2E1—Dexamethasone—hematologic cancer	0.00692	0.00989	CbGbCtD
Tranylcypromine—CYP3A4—Daunorubicin—hematologic cancer	0.00666	0.00951	CbGbCtD
Tranylcypromine—CYP3A4—Cytarabine—hematologic cancer	0.00587	0.00839	CbGbCtD
Tranylcypromine—CYP3A4—Teniposide—hematologic cancer	0.00578	0.00826	CbGbCtD
Tranylcypromine—CYP3A4—Ifosfamide—hematologic cancer	0.00534	0.00762	CbGbCtD
Tranylcypromine—CYP3A4—Imatinib—hematologic cancer	0.0051	0.00728	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—hematologic cancer	0.00487	0.00695	CbGbCtD
Tranylcypromine—CYP3A4—Ruxolitinib—hematologic cancer	0.0048	0.00686	CbGbCtD
Tranylcypromine—CYP3A4—Nilotinib—hematologic cancer	0.00463	0.00662	CbGbCtD
Tranylcypromine—CYP3A4—Vinorelbine—hematologic cancer	0.0046	0.00656	CbGbCtD
Tranylcypromine—CYP2C9—Cisplatin—hematologic cancer	0.00447	0.00638	CbGbCtD
Tranylcypromine—CYP2D6—Vinblastine—hematologic cancer	0.00445	0.00636	CbGbCtD
Tranylcypromine—CYP2C19—Dexamethasone—hematologic cancer	0.00434	0.0062	CbGbCtD
Tranylcypromine—CYP3A4—Triamcinolone—hematologic cancer	0.0042	0.006	CbGbCtD
Tranylcypromine—CYP3A4—Dasatinib—hematologic cancer	0.0041	0.00585	CbGbCtD
Tranylcypromine—CYP3A4—Mitoxantrone—hematologic cancer	0.00405	0.00578	CbGbCtD
Tranylcypromine—CYP2C9—Dexamethasone—hematologic cancer	0.00361	0.00515	CbGbCtD
Tranylcypromine—CYP3A4—Betamethasone—hematologic cancer	0.00361	0.00515	CbGbCtD
Tranylcypromine—CYP3A4—Prednisolone—hematologic cancer	0.00356	0.00508	CbGbCtD
Tranylcypromine—CYP3A4—Prednisone—hematologic cancer	0.00336	0.0048	CbGbCtD
Tranylcypromine—CYP2D6—Dexamethasone—hematologic cancer	0.0033	0.00471	CbGbCtD
Tranylcypromine—CYP3A4—Irinotecan—hematologic cancer	0.00319	0.00455	CbGbCtD
Tranylcypromine—CYP3A4—Vinblastine—hematologic cancer	0.00283	0.00404	CbGbCtD
Tranylcypromine—CYP3A4—Vincristine—hematologic cancer	0.00278	0.00398	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—hematologic cancer	0.00274	0.00391	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—hematologic cancer	0.00255	0.00364	CbGbCtD
Tranylcypromine—CYP3A4—Dexamethasone—hematologic cancer	0.0021	0.003	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—hematologic cancer	0.00174	0.00249	CbGbCtD
Tranylcypromine—MAOB—hematopoietic system—hematologic cancer	0.000538	0.0684	CbGeAlD
Tranylcypromine—CYP2C19—hematopoietic system—hematologic cancer	0.000469	0.0596	CbGeAlD
Tranylcypromine—MAOA—hematopoietic system—hematologic cancer	0.000459	0.0583	CbGeAlD
Tranylcypromine—CYP2A6—lung—hematologic cancer	0.000423	0.0538	CbGeAlD
Tranylcypromine—CYP1A2—hematopoietic system—hematologic cancer	0.000383	0.0487	CbGeAlD
Tranylcypromine—CYP2C9—hematopoietic system—hematologic cancer	0.000363	0.0462	CbGeAlD
Tranylcypromine—MAOB—blood—hematologic cancer	0.000356	0.0453	CbGeAlD
Tranylcypromine—CYP2E1—hematopoietic system—hematologic cancer	0.000344	0.0438	CbGeAlD
Tranylcypromine—MAOB—lung—hematologic cancer	0.000312	0.0397	CbGeAlD
Tranylcypromine—CYP2C19—blood—hematologic cancer	0.000311	0.0395	CbGeAlD
Tranylcypromine—MAOA—blood—hematologic cancer	0.000304	0.0386	CbGeAlD
Tranylcypromine—MAOB—testis—hematologic cancer	0.000295	0.0375	CbGeAlD
Tranylcypromine—CYP3A4—hematopoietic system—hematologic cancer	0.000277	0.0352	CbGeAlD
Tranylcypromine—CYP2D6—hematopoietic system—hematologic cancer	0.000273	0.0347	CbGeAlD
Tranylcypromine—MAOA—lung—hematologic cancer	0.000267	0.0339	CbGeAlD
Tranylcypromine—CYP1A2—blood—hematologic cancer	0.000254	0.0322	CbGeAlD
Tranylcypromine—MAOA—testis—hematologic cancer	0.000252	0.032	CbGeAlD
Tranylcypromine—CYP2C9—blood—hematologic cancer	0.000241	0.0306	CbGeAlD
Tranylcypromine—CYP2E1—blood—hematologic cancer	0.000228	0.029	CbGeAlD
Tranylcypromine—CYP1A2—lung—hematologic cancer	0.000222	0.0283	CbGeAlD
Tranylcypromine—MAOB—lymph node—hematologic cancer	0.000214	0.0272	CbGeAlD
Tranylcypromine—CYP2E1—lung—hematologic cancer	0.0002	0.0254	CbGeAlD
Tranylcypromine—CYP2E1—testis—hematologic cancer	0.000189	0.024	CbGeAlD
Tranylcypromine—CYP3A4—blood—hematologic cancer	0.000184	0.0233	CbGeAlD
Tranylcypromine—MAOA—lymph node—hematologic cancer	0.000182	0.0232	CbGeAlD
Tranylcypromine—CYP2D6—blood—hematologic cancer	0.000181	0.023	CbGeAlD
Tranylcypromine—CYP2D6—testis—hematologic cancer	0.000149	0.019	CbGeAlD
Tranylcypromine—Rash—Ifosfamide—hematologic cancer	5.82e-05	0.000246	CcSEcCtD
Tranylcypromine—Dermatitis—Ifosfamide—hematologic cancer	5.81e-05	0.000246	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Dexamethasone—hematologic cancer	5.8e-05	0.000245	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Betamethasone—hematologic cancer	5.8e-05	0.000245	CcSEcCtD
Tranylcypromine—Dizziness—Irinotecan—hematologic cancer	5.79e-05	0.000245	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—hematologic cancer	5.79e-05	0.000245	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—hematologic cancer	5.78e-05	0.000244	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—hematologic cancer	5.76e-05	0.000244	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—hematologic cancer	5.76e-05	0.000244	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—hematologic cancer	5.75e-05	0.000243	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—hematologic cancer	5.75e-05	0.000243	CcSEcCtD
Tranylcypromine—Syncope—Prednisone—hematologic cancer	5.74e-05	0.000243	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—hematologic cancer	5.73e-05	0.000242	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—hematologic cancer	5.72e-05	0.000242	CcSEcCtD
Tranylcypromine—Vomiting—Vincristine—hematologic cancer	5.72e-05	0.000242	CcSEcCtD
Tranylcypromine—Anorexia—Dexamethasone—hematologic cancer	5.72e-05	0.000242	CcSEcCtD
Tranylcypromine—Anorexia—Betamethasone—hematologic cancer	5.72e-05	0.000242	CcSEcCtD
Tranylcypromine—Urticaria—Prednisolone—hematologic cancer	5.71e-05	0.000242	CcSEcCtD
Tranylcypromine—Asthenia—Cisplatin—hematologic cancer	5.71e-05	0.000241	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—hematologic cancer	5.68e-05	0.00024	CcSEcCtD
Tranylcypromine—Rash—Vincristine—hematologic cancer	5.67e-05	0.00024	CcSEcCtD
Tranylcypromine—Dermatitis—Vincristine—hematologic cancer	5.67e-05	0.00024	CcSEcCtD
Tranylcypromine—Pain—Triamcinolone—hematologic cancer	5.65e-05	0.000239	CcSEcCtD
Tranylcypromine—Headache—Vincristine—hematologic cancer	5.64e-05	0.000238	CcSEcCtD
Tranylcypromine—Loss of consciousness—Prednisone—hematologic cancer	5.63e-05	0.000238	CcSEcCtD
Tranylcypromine—Hypotension—Dexamethasone—hematologic cancer	5.61e-05	0.000237	CcSEcCtD
Tranylcypromine—Hypotension—Betamethasone—hematologic cancer	5.61e-05	0.000237	CcSEcCtD
Tranylcypromine—Nausea—Carmustine—hematologic cancer	5.6e-05	0.000237	CcSEcCtD
Tranylcypromine—Vomiting—Mitoxantrone—hematologic cancer	5.57e-05	0.000236	CcSEcCtD
Tranylcypromine—Vomiting—Irinotecan—hematologic cancer	5.57e-05	0.000236	CcSEcCtD
Tranylcypromine—Nausea—Alitretinoin—hematologic cancer	5.55e-05	0.000235	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—hematologic cancer	5.53e-05	0.000234	CcSEcCtD
Tranylcypromine—Hypertension—Prednisone—hematologic cancer	5.53e-05	0.000234	CcSEcCtD
Tranylcypromine—Rash—Mitoxantrone—hematologic cancer	5.52e-05	0.000234	CcSEcCtD
Tranylcypromine—Rash—Irinotecan—hematologic cancer	5.52e-05	0.000234	CcSEcCtD
Tranylcypromine—Dermatitis—Irinotecan—hematologic cancer	5.52e-05	0.000233	CcSEcCtD
Tranylcypromine—Dermatitis—Mitoxantrone—hematologic cancer	5.52e-05	0.000233	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—hematologic cancer	5.51e-05	0.000233	CcSEcCtD
Tranylcypromine—Headache—Irinotecan—hematologic cancer	5.49e-05	0.000232	CcSEcCtD
Tranylcypromine—Headache—Mitoxantrone—hematologic cancer	5.49e-05	0.000232	CcSEcCtD
Tranylcypromine—Nausea—Ifosfamide—hematologic cancer	5.48e-05	0.000232	CcSEcCtD
Tranylcypromine—Feeling abnormal—Triamcinolone—hematologic cancer	5.45e-05	0.00023	CcSEcCtD
Tranylcypromine—Diarrhoea—Cisplatin—hematologic cancer	5.44e-05	0.00023	CcSEcCtD
Tranylcypromine—Anxiety—Prednisone—hematologic cancer	5.43e-05	0.00023	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—hematologic cancer	5.43e-05	0.00023	CcSEcCtD
Tranylcypromine—Vomiting—Gemcitabine—hematologic cancer	5.43e-05	0.00023	CcSEcCtD
Tranylcypromine—Insomnia—Betamethasone—hematologic cancer	5.43e-05	0.000229	CcSEcCtD
Tranylcypromine—Insomnia—Dexamethasone—hematologic cancer	5.43e-05	0.000229	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—hematologic cancer	5.42e-05	0.000229	CcSEcCtD
Tranylcypromine—Paraesthesia—Dexamethasone—hematologic cancer	5.39e-05	0.000228	CcSEcCtD
Tranylcypromine—Paraesthesia—Betamethasone—hematologic cancer	5.39e-05	0.000228	CcSEcCtD
Tranylcypromine—Rash—Gemcitabine—hematologic cancer	5.38e-05	0.000228	CcSEcCtD
Tranylcypromine—Dermatitis—Gemcitabine—hematologic cancer	5.38e-05	0.000227	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—hematologic cancer	5.36e-05	0.000227	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—hematologic cancer	5.35e-05	0.000226	CcSEcCtD
Tranylcypromine—Headache—Gemcitabine—hematologic cancer	5.35e-05	0.000226	CcSEcCtD
Tranylcypromine—Nausea—Vincristine—hematologic cancer	5.34e-05	0.000226	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—hematologic cancer	5.34e-05	0.000226	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—hematologic cancer	5.32e-05	0.000225	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—hematologic cancer	5.32e-05	0.000225	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—hematologic cancer	5.29e-05	0.000224	CcSEcCtD
Tranylcypromine—Urticaria—Triamcinolone—hematologic cancer	5.25e-05	0.000222	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—hematologic cancer	5.23e-05	0.000221	CcSEcCtD
Tranylcypromine—Body temperature increased—Triamcinolone—hematologic cancer	5.23e-05	0.000221	CcSEcCtD
Tranylcypromine—Oedema—Prednisone—hematologic cancer	5.22e-05	0.000221	CcSEcCtD
Tranylcypromine—Decreased appetite—Dexamethasone—hematologic cancer	5.21e-05	0.000221	CcSEcCtD
Tranylcypromine—Decreased appetite—Betamethasone—hematologic cancer	5.21e-05	0.000221	CcSEcCtD
Tranylcypromine—Nausea—Irinotecan—hematologic cancer	5.2e-05	0.00022	CcSEcCtD
Tranylcypromine—Nausea—Mitoxantrone—hematologic cancer	5.2e-05	0.00022	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—hematologic cancer	5.16e-05	0.000218	CcSEcCtD
Tranylcypromine—Shock—Prednisone—hematologic cancer	5.14e-05	0.000217	CcSEcCtD
Tranylcypromine—Pain—Betamethasone—hematologic cancer	5.13e-05	0.000217	CcSEcCtD
Tranylcypromine—Pain—Dexamethasone—hematologic cancer	5.13e-05	0.000217	CcSEcCtD
Tranylcypromine—Tachycardia—Prednisone—hematologic cancer	5.1e-05	0.000216	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—hematologic cancer	5.08e-05	0.000215	CcSEcCtD
Tranylcypromine—Nausea—Gemcitabine—hematologic cancer	5.07e-05	0.000214	CcSEcCtD
Tranylcypromine—Vomiting—Cisplatin—hematologic cancer	5.06e-05	0.000214	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Prednisone—hematologic cancer	5.05e-05	0.000214	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—hematologic cancer	5.04e-05	0.000213	CcSEcCtD
Tranylcypromine—Rash—Cisplatin—hematologic cancer	5.02e-05	0.000212	CcSEcCtD
Tranylcypromine—Dermatitis—Cisplatin—hematologic cancer	5.01e-05	0.000212	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—hematologic cancer	4.99e-05	0.000211	CcSEcCtD
Tranylcypromine—Anorexia—Prednisone—hematologic cancer	4.98e-05	0.000211	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—hematologic cancer	4.96e-05	0.00021	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Tranylcypromine—Feeling abnormal—Betamethasone—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Tranylcypromine—Feeling abnormal—Dexamethasone—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—hematologic cancer	4.94e-05	0.000209	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.9e-05	0.000207	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Betamethasone—hematologic cancer	4.9e-05	0.000207	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—hematologic cancer	4.82e-05	0.000204	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—hematologic cancer	4.81e-05	0.000204	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—hematologic cancer	4.79e-05	0.000203	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Tranylcypromine—Urticaria—Betamethasone—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Tranylcypromine—Urticaria—Dexamethasone—hematologic cancer	4.77e-05	0.000202	CcSEcCtD
Tranylcypromine—Dizziness—Prednisolone—hematologic cancer	4.75e-05	0.000201	CcSEcCtD
Tranylcypromine—Asthenia—Triamcinolone—hematologic cancer	4.74e-05	0.000201	CcSEcCtD
Tranylcypromine—Body temperature increased—Dexamethasone—hematologic cancer	4.74e-05	0.000201	CcSEcCtD
Tranylcypromine—Abdominal pain—Betamethasone—hematologic cancer	4.74e-05	0.000201	CcSEcCtD
Tranylcypromine—Abdominal pain—Dexamethasone—hematologic cancer	4.74e-05	0.000201	CcSEcCtD
Tranylcypromine—Body temperature increased—Betamethasone—hematologic cancer	4.74e-05	0.000201	CcSEcCtD
Tranylcypromine—Nausea—Cisplatin—hematologic cancer	4.73e-05	0.0002	CcSEcCtD
Tranylcypromine—Insomnia—Prednisone—hematologic cancer	4.72e-05	0.0002	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—hematologic cancer	4.72e-05	0.0002	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—hematologic cancer	4.7e-05	0.000199	CcSEcCtD
Tranylcypromine—Paraesthesia—Prednisone—hematologic cancer	4.69e-05	0.000198	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—hematologic cancer	4.63e-05	0.000196	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—hematologic cancer	4.63e-05	0.000196	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—hematologic cancer	4.6e-05	0.000195	CcSEcCtD
Tranylcypromine—Rash—Etoposide—hematologic cancer	4.6e-05	0.000194	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—hematologic cancer	4.59e-05	0.000194	CcSEcCtD
Tranylcypromine—Headache—Etoposide—hematologic cancer	4.57e-05	0.000193	CcSEcCtD
Tranylcypromine—Decreased appetite—Prednisone—hematologic cancer	4.54e-05	0.000192	CcSEcCtD
Tranylcypromine—Rash—Prednisolone—hematologic cancer	4.53e-05	0.000192	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisolone—hematologic cancer	4.53e-05	0.000192	CcSEcCtD
Tranylcypromine—Headache—Prednisolone—hematologic cancer	4.5e-05	0.00019	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—hematologic cancer	4.49e-05	0.00019	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—hematologic cancer	4.48e-05	0.00019	CcSEcCtD
Tranylcypromine—Constipation—Prednisone—hematologic cancer	4.47e-05	0.000189	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—hematologic cancer	4.45e-05	0.000188	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—hematologic cancer	4.42e-05	0.000187	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—hematologic cancer	4.4e-05	0.000186	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—hematologic cancer	4.4e-05	0.000186	CcSEcCtD
Tranylcypromine—Dizziness—Triamcinolone—hematologic cancer	4.37e-05	0.000185	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—hematologic cancer	4.37e-05	0.000185	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—hematologic cancer	4.33e-05	0.000183	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—hematologic cancer	4.32e-05	0.000183	CcSEcCtD
Tranylcypromine—Feeling abnormal—Prednisone—hematologic cancer	4.3e-05	0.000182	CcSEcCtD
Tranylcypromine—Asthenia—Dexamethasone—hematologic cancer	4.3e-05	0.000182	CcSEcCtD
Tranylcypromine—Asthenia—Betamethasone—hematologic cancer	4.3e-05	0.000182	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—hematologic cancer	4.28e-05	0.000181	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—hematologic cancer	4.27e-05	0.000181	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Prednisone—hematologic cancer	4.27e-05	0.000181	CcSEcCtD
Tranylcypromine—Nausea—Prednisolone—hematologic cancer	4.27e-05	0.000181	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—hematologic cancer	4.26e-05	0.00018	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—hematologic cancer	4.25e-05	0.00018	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—hematologic cancer	4.22e-05	0.000179	CcSEcCtD
Tranylcypromine—Vomiting—Triamcinolone—hematologic cancer	4.2e-05	0.000178	CcSEcCtD
Tranylcypromine—Rash—Triamcinolone—hematologic cancer	4.17e-05	0.000176	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—hematologic cancer	4.17e-05	0.000176	CcSEcCtD
Tranylcypromine—Dermatitis—Triamcinolone—hematologic cancer	4.16e-05	0.000176	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—hematologic cancer	4.16e-05	0.000176	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—hematologic cancer	4.15e-05	0.000176	CcSEcCtD
Tranylcypromine—Urticaria—Prednisone—hematologic cancer	4.15e-05	0.000176	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—hematologic cancer	4.15e-05	0.000175	CcSEcCtD
Tranylcypromine—Headache—Triamcinolone—hematologic cancer	4.14e-05	0.000175	CcSEcCtD
Tranylcypromine—Abdominal pain—Prednisone—hematologic cancer	4.13e-05	0.000175	CcSEcCtD
Tranylcypromine—Body temperature increased—Prednisone—hematologic cancer	4.13e-05	0.000175	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—hematologic cancer	4.12e-05	0.000174	CcSEcCtD
Tranylcypromine—Diarrhoea—Dexamethasone—hematologic cancer	4.1e-05	0.000174	CcSEcCtD
Tranylcypromine—Diarrhoea—Betamethasone—hematologic cancer	4.1e-05	0.000174	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—hematologic cancer	4.09e-05	0.000173	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—hematologic cancer	4.09e-05	0.000173	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—hematologic cancer	4.08e-05	0.000173	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—hematologic cancer	4.07e-05	0.000172	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—hematologic cancer	4.02e-05	0.00017	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—hematologic cancer	4e-05	0.000169	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—hematologic cancer	4e-05	0.000169	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—hematologic cancer	3.99e-05	0.000169	CcSEcCtD
Tranylcypromine—Dizziness—Dexamethasone—hematologic cancer	3.97e-05	0.000168	CcSEcCtD
Tranylcypromine—Dizziness—Betamethasone—hematologic cancer	3.97e-05	0.000168	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—hematologic cancer	3.95e-05	0.000167	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—hematologic cancer	3.95e-05	0.000167	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—hematologic cancer	3.93e-05	0.000166	CcSEcCtD
Tranylcypromine—Nausea—Triamcinolone—hematologic cancer	3.93e-05	0.000166	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—hematologic cancer	3.92e-05	0.000166	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—hematologic cancer	3.89e-05	0.000165	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—hematologic cancer	3.88e-05	0.000164	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—hematologic cancer	3.86e-05	0.000163	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—hematologic cancer	3.82e-05	0.000161	CcSEcCtD
Tranylcypromine—Vomiting—Betamethasone—hematologic cancer	3.81e-05	0.000161	CcSEcCtD
Tranylcypromine—Vomiting—Dexamethasone—hematologic cancer	3.81e-05	0.000161	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—hematologic cancer	3.81e-05	0.000161	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—hematologic cancer	3.8e-05	0.000161	CcSEcCtD
Tranylcypromine—Rash—Betamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Tranylcypromine—Rash—Dexamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Tranylcypromine—Dermatitis—Dexamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Tranylcypromine—Dermatitis—Betamethasone—hematologic cancer	3.78e-05	0.00016	CcSEcCtD
Tranylcypromine—Headache—Dexamethasone—hematologic cancer	3.76e-05	0.000159	CcSEcCtD
Tranylcypromine—Headache—Betamethasone—hematologic cancer	3.76e-05	0.000159	CcSEcCtD
Tranylcypromine—Asthenia—Prednisone—hematologic cancer	3.75e-05	0.000159	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—hematologic cancer	3.73e-05	0.000158	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—hematologic cancer	3.72e-05	0.000157	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.7e-05	0.000157	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—hematologic cancer	3.7e-05	0.000156	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—hematologic cancer	3.69e-05	0.000156	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—hematologic cancer	3.67e-05	0.000155	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.65e-05	0.000155	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—hematologic cancer	3.63e-05	0.000154	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—hematologic cancer	3.6e-05	0.000152	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—hematologic cancer	3.6e-05	0.000152	CcSEcCtD
Tranylcypromine—Diarrhoea—Prednisone—hematologic cancer	3.57e-05	0.000151	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.57e-05	0.000151	CcSEcCtD
Tranylcypromine—Nausea—Dexamethasone—hematologic cancer	3.56e-05	0.000151	CcSEcCtD
Tranylcypromine—Nausea—Betamethasone—hematologic cancer	3.56e-05	0.000151	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—hematologic cancer	3.55e-05	0.00015	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—hematologic cancer	3.53e-05	0.000149	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—hematologic cancer	3.49e-05	0.000148	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—hematologic cancer	3.49e-05	0.000148	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—hematologic cancer	3.47e-05	0.000147	CcSEcCtD
Tranylcypromine—Dizziness—Prednisone—hematologic cancer	3.45e-05	0.000146	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—hematologic cancer	3.45e-05	0.000146	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—hematologic cancer	3.45e-05	0.000146	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—hematologic cancer	3.42e-05	0.000145	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—hematologic cancer	3.39e-05	0.000144	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—hematologic cancer	3.37e-05	0.000142	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—hematologic cancer	3.36e-05	0.000142	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.34e-05	0.000141	CcSEcCtD
Tranylcypromine—Vomiting—Prednisone—hematologic cancer	3.32e-05	0.00014	CcSEcCtD
Tranylcypromine—Rash—Prednisone—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Tranylcypromine—Dermatitis—Prednisone—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—hematologic cancer	3.29e-05	0.000139	CcSEcCtD
Tranylcypromine—Headache—Prednisone—hematologic cancer	3.27e-05	0.000138	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—hematologic cancer	3.25e-05	0.000137	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—hematologic cancer	3.23e-05	0.000137	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—hematologic cancer	3.23e-05	0.000137	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—hematologic cancer	3.23e-05	0.000137	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—hematologic cancer	3.23e-05	0.000137	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—hematologic cancer	3.13e-05	0.000132	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—hematologic cancer	3.12e-05	0.000132	CcSEcCtD
Tranylcypromine—Nausea—Prednisone—hematologic cancer	3.1e-05	0.000131	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.09e-05	0.000131	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—hematologic cancer	3e-05	0.000127	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—hematologic cancer	2.99e-05	0.000126	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—hematologic cancer	2.99e-05	0.000126	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—hematologic cancer	2.99e-05	0.000126	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—hematologic cancer	2.93e-05	0.000124	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—hematologic cancer	2.89e-05	0.000122	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—hematologic cancer	2.8e-05	0.000118	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—hematologic cancer	2.78e-05	0.000117	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—hematologic cancer	2.75e-05	0.000116	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—hematologic cancer	2.75e-05	0.000116	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—hematologic cancer	2.73e-05	0.000116	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—hematologic cancer	2.71e-05	0.000115	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—hematologic cancer	2.7e-05	0.000114	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—hematologic cancer	2.6e-05	0.00011	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—hematologic cancer	2.59e-05	0.00011	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—hematologic cancer	2.59e-05	0.000109	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—hematologic cancer	2.58e-05	0.000109	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—hematologic cancer	2.57e-05	0.000109	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—hematologic cancer	2.56e-05	0.000108	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—hematologic cancer	2.5e-05	0.000106	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—hematologic cancer	2.43e-05	0.000103	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—hematologic cancer	2.4e-05	0.000102	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—hematologic cancer	2.38e-05	0.000101	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—hematologic cancer	2.37e-05	0.0001	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—hematologic cancer	2.25e-05	9.5e-05	CcSEcCtD
Tranylcypromine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.32e-06	0.000132	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTAP—hematologic cancer	7.29e-06	0.000131	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.18e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.18e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ACP5—hematologic cancer	7.15e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CA9—hematologic cancer	7.15e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.15e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.15e-06	0.000129	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NQO1—hematologic cancer	7.13e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CD44—hematologic cancer	7.13e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ABCB1—hematologic cancer	7.12e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.12e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.12e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NUP214—hematologic cancer	7.1e-06	0.000128	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOR2—hematologic cancer	7.06e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.03e-06	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALOX5—hematologic cancer	7e-06	0.000126	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—hematologic cancer	6.98e-06	0.000126	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCG2—hematologic cancer	6.96e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTR—hematologic cancer	6.96e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALOX5—hematologic cancer	6.94e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NCOR1—hematologic cancer	6.92e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—hematologic cancer	6.92e-06	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ENO2—hematologic cancer	6.82e-06	0.000123	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NUP98—hematologic cancer	6.78e-06	0.000122	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYCS—hematologic cancer	6.75e-06	0.000122	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—IDH1—hematologic cancer	6.73e-06	0.000121	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NUP98—hematologic cancer	6.72e-06	0.000121	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	6.7e-06	0.000121	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—EP300—hematologic cancer	6.66e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCC3—hematologic cancer	6.65e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TXN—hematologic cancer	6.65e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTO1—hematologic cancer	6.65e-06	0.00012	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.62e-06	0.000119	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CG—hematologic cancer	6.61e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.58e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.58e-06	0.000119	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NUP214—hematologic cancer	6.53e-06	0.000118	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.52e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.52e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.52e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SPHK1—hematologic cancer	6.51e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—FHL2—hematologic cancer	6.49e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NUP214—hematologic cancer	6.48e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SDC1—hematologic cancer	6.47e-06	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.41e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.4e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTR—hematologic cancer	6.4e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AGRN—hematologic cancer	6.37e-06	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.35e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTR—hematologic cancer	6.35e-06	0.000114	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ENO2—hematologic cancer	6.28e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	6.25e-06	0.000113	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ENO2—hematologic cancer	6.22e-06	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.18e-06	0.000111	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CREBBP—hematologic cancer	6.13e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—hematologic cancer	6.11e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.1e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.09e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	6.08e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CRABP1—hematologic cancer	6.08e-06	0.00011	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.04e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.04e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.04e-06	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SDC1—hematologic cancer	5.95e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—hematologic cancer	5.95e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.94e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.93e-06	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SDC1—hematologic cancer	5.9e-06	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.84e-06	0.000105	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CD—hematologic cancer	5.81e-06	0.000105	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NUP98—hematologic cancer	5.74e-06	0.000103	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ALB—hematologic cancer	5.74e-06	0.000103	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.68e-06	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.63e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ABCB1—hematologic cancer	5.63e-06	0.000101	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ADCY7—hematologic cancer	5.57e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOA3—hematologic cancer	5.57e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.56e-06	0.0001	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NUP214—hematologic cancer	5.53e-06	9.97e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ACP5—hematologic cancer	5.52e-06	9.94e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CA9—hematologic cancer	5.52e-06	9.94e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CD44—hematologic cancer	5.5e-06	9.91e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NQO1—hematologic cancer	5.5e-06	9.91e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3R1—hematologic cancer	5.49e-06	9.89e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.48e-06	9.86e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NCOR1—hematologic cancer	5.46e-06	9.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—hematologic cancer	5.46e-06	9.84e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.45e-06	9.82e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTR—hematologic cancer	5.42e-06	9.77e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCG2—hematologic cancer	5.42e-06	9.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.39e-06	9.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.32e-06	9.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ENO2—hematologic cancer	5.32e-06	9.58e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.21e-06	9.37e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.19e-06	9.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.17e-06	9.31e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—hematologic cancer	5.16e-06	9.29e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CG—hematologic cancer	5.13e-06	9.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.13e-06	9.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.13e-06	9.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TXN—hematologic cancer	5.13e-06	9.25e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.08e-06	9.15e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CB—hematologic cancer	5.07e-06	9.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CD44—hematologic cancer	5.06e-06	9.11e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NQO1—hematologic cancer	5.06e-06	9.11e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SDC1—hematologic cancer	5.04e-06	9.08e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.02e-06	9.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NQO1—hematologic cancer	5.02e-06	9.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CD44—hematologic cancer	5.02e-06	9.03e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PIK3CA—hematologic cancer	4.92e-06	8.87e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.91e-06	8.85e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—hematologic cancer	4.83e-06	8.7e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.83e-06	8.69e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.82e-06	8.67e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYCS—hematologic cancer	4.79e-06	8.62e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CREBBP—hematologic cancer	4.76e-06	8.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.76e-06	8.57e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.75e-06	8.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYCS—hematologic cancer	4.75e-06	8.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.72e-06	8.49e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.7e-06	8.46e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.7e-06	8.46e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.65e-06	8.38e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.59e-06	8.26e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.58e-06	8.24e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.55e-06	8.19e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CD—hematologic cancer	4.51e-06	8.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ALB—hematologic cancer	4.46e-06	8.03e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.44e-06	7.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.43e-06	7.98e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—hematologic cancer	4.38e-06	7.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.34e-06	7.82e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.3e-06	7.75e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.3e-06	7.75e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CD44—hematologic cancer	4.29e-06	7.72e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NQO1—hematologic cancer	4.29e-06	7.72e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.27e-06	7.69e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3R1—hematologic cancer	4.26e-06	7.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.24e-06	7.64e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.22e-06	7.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.22e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.22e-06	7.59e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.2e-06	7.56e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTR—hematologic cancer	4.18e-06	7.54e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.18e-06	7.54e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.18e-06	7.53e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—EP300—hematologic cancer	4.18e-06	7.52e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.1e-06	7.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	4.06e-06	7.31e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYCS—hematologic cancer	4.06e-06	7.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.05e-06	7.29e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	4.03e-06	7.26e-05	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—AKT1—hematologic cancer	4.02e-06	7.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.99e-06	7.19e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.98e-06	7.17e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ABCB1—hematologic cancer	3.96e-06	7.13e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CB—hematologic cancer	3.93e-06	7.09e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SDC1—hematologic cancer	3.89e-06	7.01e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.88e-06	6.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.88e-06	6.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.84e-06	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.84e-06	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CREBBP—hematologic cancer	3.76e-06	6.78e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.73e-06	6.71e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.63e-06	6.53e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.57e-06	6.44e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	3.57e-06	6.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ALB—hematologic cancer	3.52e-06	6.34e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.46e-06	6.23e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.43e-06	6.17e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—hematologic cancer	3.4e-06	6.12e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.4e-06	6.12e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ABCB1—hematologic cancer	3.38e-06	6.09e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	3.37e-06	6.07e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.31e-06	5.96e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CD44—hematologic cancer	3.31e-06	5.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—hematologic cancer	3.29e-06	5.92e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOR1—hematologic cancer	3.29e-06	5.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.28e-06	5.91e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—EP300—hematologic cancer	3.24e-06	5.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.13e-06	5.64e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.13e-06	5.64e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.11e-06	5.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	3.11e-06	5.6e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PIK3CA—hematologic cancer	3.09e-06	5.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.99e-06	5.39e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.9e-06	5.23e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.9e-06	5.23e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.88e-06	5.19e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.85e-06	5.14e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.76e-06	4.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.75e-06	4.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ALB—hematologic cancer	2.72e-06	4.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—hematologic cancer	2.69e-06	4.84e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.67e-06	4.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.65e-06	4.77e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.61e-06	4.7e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.6e-06	4.68e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—EP300—hematologic cancer	2.56e-06	4.61e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.56e-06	4.61e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.54e-06	4.57e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.54e-06	4.57e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.53e-06	4.56e-05	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—AKT1—hematologic cancer	2.52e-06	4.55e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.51e-06	4.52e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ALB—hematologic cancer	2.5e-06	4.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ALB—hematologic cancer	2.48e-06	4.46e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.44e-06	4.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.4e-06	4.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PIK3CA—hematologic cancer	2.4e-06	4.32e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.39e-06	4.3e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.37e-06	4.27e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.26e-06	4.07e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.24e-06	4.04e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.21e-06	3.97e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.19e-06	3.94e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.14e-06	3.86e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ALB—hematologic cancer	2.12e-06	3.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.07e-06	3.73e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.02e-06	3.65e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—EP300—hematologic cancer	1.98e-06	3.56e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—AKT1—hematologic cancer	1.96e-06	3.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.91e-06	3.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.9e-06	3.41e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.89e-06	3.4e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.88e-06	3.39e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.87e-06	3.37e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—EP300—hematologic cancer	1.82e-06	3.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—EP300—hematologic cancer	1.8e-06	3.25e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.75e-06	3.14e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.65e-06	2.98e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ALB—hematologic cancer	1.63e-06	2.94e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.62e-06	2.91e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.56e-06	2.81e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.55e-06	2.79e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—EP300—hematologic cancer	1.54e-06	2.77e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.46e-06	2.63e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.44e-06	2.6e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.35e-06	2.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.33e-06	2.4e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.25e-06	2.24e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.19e-06	2.15e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—EP300—hematologic cancer	1.19e-06	2.14e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.14e-06	2.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.1e-06	1.98e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.09e-06	1.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—AKT1—hematologic cancer	9.31e-07	1.68e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.79e-07	1.58e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—AKT1—hematologic cancer	7.18e-07	1.29e-05	CbGpPWpGaD
